Top Tech Companies in Boston, MA (4,804)

Strong Revenue Growth: Revenue is growing at double-digit rates, with Q2 2026 up 27% year over year and first-half 2026 up about 25%. Management also raised full-year 2026 guidance to $94–96 million, implying approximately 22–24% growth.

Market Expansion: U.S. activity accelerated, with U.S. analysis volume up 60% year over year in Q2 2026 and major health-system additions. Core genomics customers increased to 542 as of June 30, 2026, from 490 a year earlier.

Customer Loyalty & Retention: Net dollar retention improved to 117% in Q2 2026 (versus 107% a year earlier), indicating greater spending within the installed base. Platform usage also reached a record 115,000 analyses in Q2 2026, up 22% year over year.

Investor Backing & Capital Strength: A majority investment by Nordic Capital and a $125 million financing from Vista Credit Partners are described as fueling accelerated innovation and scale. These developments signal ample capital access to support ongoing expansion.

Product Line Growth: The CareJourney acquisition and subsequent launches of expanded suites (e.g., Ascent, CareJourney, LifeScience) and AI-enabled capabilities broaden the platform’s functionality. These moves indicate a deliberate build-out of offerings across providers, payers, and life sciences.

Market Expansion: New customer business reportedly added more than 2.25 million value-based lives and brought the ecosystem to over 170 million patient records, with the combined portfolio approaching 200 organizations. Active customer and partner engagement at Aggregate 2025 further suggests a deepening commercial footprint.

Strong Revenue Growth: Reporting indicates revenue increased in successive years, with UK results showing clear year-over-year gains and the parent highlighting category increases linked to the business. This pattern points to solid top-line momentum across core operations.

Profitability: Operating and post-tax profit improved materially, at times outpacing revenue growth. Such margin expansion suggests enhanced earning efficiency and disciplined execution.

Market Expansion: Customer reach advanced to a major UK milestone while U.S. distribution broadened through accelerated agent activity and additional channels. New insurer partnerships and digital launches further extend access to buyers.

Strong Revenue Growth: Revenue is increasing at a double‑digit pace, with Q2 2026 revenue of about $1.91B up year over year. Full-year 2025 revenue also rose meaningfully to roughly $6.15B from $4.96B the prior year, indicating momentum across periods.

Profitability: Profitability is improving, as Q2 2026 net income increased to about $154M and operating income to roughly $152M from the prior year’s quarter. Recurring gross profit from subscription and fintech reached approximately $585M, showing stronger unit economics alongside scale.

Market Expansion: Customer reach is widening, with roughly 9,500 net locations added in Q2 2026 and total locations around 180,000, both higher than a year earlier. The company is also extending into retail, enterprise, international markets, and AI-enabled products such as Toast IQ.

Strong Revenue Growth: Revenue is rising at a low-double-digit pace, with FY 2025 up 14% and Q1–Q2 2026 growing 15% and 13% year over year. Evidence indicates this marked a second consecutive year of double-digit annual growth with continued momentum into 2026.

Profitability: Profitability expanded faster than sales in 2025, with adjusted EBITDA up 25% and GAAP net income from continuing operations up 53%. This pattern points to improved operating leverage, even as quarterly results vary.

Market Expansion: International and dealer-network metrics show expansion, with total paying dealers up about 5% and international dealers up 11% year over year; international revenue rose 28% in Q2 2026. These gains suggest growth beyond the U.S. base and higher monetization per dealer.

Strong Revenue Growth: Revenue is rising at a reported 48% in 2025, with annualized revenue surpassing $300 million and nearing $400 million by August 2026. These figures indicate rapid scaling at a substantial revenue base.

Product Line Growth: The platform has expanded beyond business travel into expenses, invoices, corporate spending, and events, reinforced by the Yokoy acquisition. This broader offering increases opportunities to sell additional services to existing customers.

Market Expansion: Geographic reach is widening, including the U.S. launch of Perk Spend and growth initiatives that made the U.S. account for about 30% of global new business. Additional international moves, such as new offices, support continued growth outside the core markets.

Innovation-Driven Growth: Product capabilities are expanding with new AI-powered Workplace Services and a Claude integration, signaling continued investment in advanced functionality. These launches move the platform beyond basic booking into orchestration and planning.

Strategic Partnerships: Availability of the One Workplace Platform through Google Cloud Marketplace provides an enterprise procurement path that can ease adoption. This distribution channel adds a route to incremental sales opportunities.

Strong Market Position & Advantage: Being named a Leader in Gartner’s 2026 Magic Quadrant for Workplace Experience Applications indicates competitive strength in the category. This recognition supports credibility with enterprise buyers.

Investor Backing & Capital Strength: Capital raising includes a $372 million Series D in 2024 with participation from Sanofi, bringing total funding above $600 million. The stated use of proceeds was to expand the drug pipeline and AI platform, indicating a strong financial base for growth.

Product Line Growth: The portfolio has expanded through multiple in-licensing deals in 2025–2026 and now spans preclinical, Phase 1, and Phase 2 programs. Tangible execution includes dosing the first participant in the BLKR201 Phase 1 trial in June 2026, only months after licensing the asset.

Strategic Partnerships: High-profile collaborations include work with Sanofi and OpenAI to build AI tools for drug development, alongside a Sanofi licensing agreement for gusacitinib with significant potential milestone value. These relationships reinforce external validation and create pathways to scale development.

Market Expansion: Acquisitions of Lab4U in 2026 and earlier formation/acquisition of Education at Work, alongside a grant network spanning more than 100 organizations across 49 states and Puerto Rico, indicate a widening national footprint. These moves show ongoing investment in expanding access and capabilities beyond the rebrand.

Product Line Growth: Adding Lab4U expands STEM learning and career exploration offerings, while Education at Work extends into paid, flexible work-based learning. Together these initiatives broaden Britebound’s portfolio beyond digital exploration into hands-on and employer-linked programs.

Investor Backing & Capital Strength: Audited statements show total assets rising year over year and net investment returns increasing materially, supplemented by previously disclosed social-bond funding. This capital base appears to underwrite program growth, grants, and acquisitions even amid mixed operating results.

Strong Market Position & Advantage: Industry recognitions and broad payer adoption portray Zelis as a leader in pre-payment integrity and healthcare financial operations. Everest Group’s Leader designation and a Best in KLAS award reinforce competitive strength in core segments.

Strong Revenue Growth: Operating indicators and third-party outlooks point to sustained expansion in scale, payments processed, and customer footprint. Company statements describe continued double-digit top-line increases alongside rapid growth in network participation and payment volumes.

Profitability: Management characterizes growth as profitable and sustainable, with external assessments citing strong margins. This pattern indicates earnings are advancing in step with overall scale.

Strong Revenue Growth: Revenue is described as up 54% over two years, with inclusion on the Inc. 5000 and the Financial Times’ Americas’ Fastest-Growing Companies list reinforcing multi‑year expansion. These signals point to sustained commercial momentum.

Strong Hiring & Retention: Headcount reportedly expanded from about 35 in 2021 to roughly 160–175 in 2026, alongside a 48% year‑over‑year hiring increase, indicating scaled delivery capacity. Active recruitment across engineering and operations further suggests continued team growth.

Market Expansion: The company extended its footprint into EMEA (2023) and APAC (2026), beginning with hires in Australia. International hiring indicates access to new markets and service opportunities.

Strong Hiring & Retention: Employee headcount is observed to have risen from roughly 134 in 2023 to about 176 by early 2026, indicating active team expansion. Leadership additions in 2026 were framed as investments to support growth across priority industries.

Innovation-Driven Growth: New AI-focused services, including the Forward Deployed Experts offering, signal investment in turning AI strategy into execution. Company materials also highlight rising AI priority in client conversations, pointing to technology-led expansion.

Future-Ready Strategy: Recent senior appointments—including a new CFO and multiple leadership roles—are described as building the financial and organizational infrastructure to scale. Partnerships and continued enterprise focus suggest preparation for broader expansion.

Profitability: Profitability is improving markedly, with net income and underwriting results rising and a strong combined ratio in early 2026. Lower catastrophe losses and stronger investment income also supported these gains.

Investor Backing & Capital Strength: Capital strength is solidifying as equity increased and S&P upgraded core operating companies’ financial strength ratings to A+, citing improved underwriting and capitalization. This positions the company to pursue growth from a stronger balance sheet.

Future-Ready Strategy: Strategy is shifting from “fixing” to “building,” emphasizing selective, profitability-threshold growth in segments showing momentum like Global Risk Solutions. Management highlights disciplined expansion rather than growth at any cost.

Strong Revenue Growth: Reported ARR surpassed $200 million in June 2026 with five consecutive years of 100% year-over-year growth, indicating rapid scaling. Adoption breadth, including claims of powering one in six U.S. apartments, reinforces the commercial momentum behind that trajectory.

Investor Backing & Capital Strength: A $350 million round in September 2026 at a $4 billion valuation, with major existing investors participating alongside Ontario Teachers’ Pension Plan, underscores substantial access to capital. This financing signals strong confidence to fund continued product development and go-to-market expansion.

Market Expansion: Reach reportedly grew from about one in twelve U.S. apartments in 2024 to one in six in 2026, alongside plans for a second engineering hub in San Francisco. The company is also expanding from leasing into broader property-management workflows and healthcare administration.

Strong Revenue Growth: Company materials describe ARR expanding more than 50% annually over a recent three-year period, and historical disclosures cite a 522% ARR increase over four years through 2019. Third-party estimates also point to a rise from roughly $4.0M in 2023 to $6.3M in 2024.

Profitability: Company disclosures characterize the business as profitable and cash-flow positive while scaling organically without external financing. Its trust center notes it is privately held and does not provide audited financials publicly.

Innovation-Driven Growth: Product materials and third-party coverage highlight ongoing releases and newer capabilities such as AI-powered risk analytics and connected-risk reporting. Continued feature expansion and workshops around modernized board reporting indicate active investment in the platform.

Strong Revenue Growth: Evidence points to ARR reaching about $210M with continued year-over-year increases, and company statements indicate surpassing $200M in annualized revenue. Feedback suggests upselling and higher average revenue per customer support expansion from existing accounts.

Market Expansion: Adoption reportedly grew from ~410 customers in 2020 to 1,200+ by 2024, with 240 new customers added in 2024 and penetration into top-50 global biopharma firms. Feedback suggests partnerships and geographic breadth bolster reach across biotech and pharma.

Innovation-Driven Growth: Product launches in AI, automation, and broader R&D workflows, plus acquisitions and collaborations (e.g., Lilly TuneLab, NVIDIA) indicate active investment in next-generation capabilities. Feedback suggests these moves expand use cases and deepen platform integration in labs.

Profitability: Operating and net income remained positive even as revenue softened in recent quarters. This indicates an earnings base that is holding up during a period of slower demand.

Healthy Cash Flow: Free cash flow stayed positive with meaningful generation quarter to quarter, and guidance points to continued cash production. Liquidity is reinforced by a sizable balance of cash, cash equivalents, and government securities.

Future-Ready Strategy: Management is concentrating investment on the Command Platform, detection and response, exposure management, and AI-enabled security operations. This refocus aims to position the portfolio for a return to growth once the transition progresses.

Strong Revenue Growth: Recent results show revenue up 27.2% year over year in Q2 2026, with full-year 2025 revenue rising 26.6% to $623 million. Management also raised its 2026 growth outlook, reinforcing the trajectory.

Market Expansion: Client additions of 200+ across 45 countries in both Q1 and Q2 2026 and growth beyond education into travel, healthcare, and B2B indicate a broadening footprint. Education revenue outside core markets growing 30%+ further supports geographic expansion.

Profitability: Adjusted EBITDA increased 44.5% in Q2 2026 with margin expansion, and full-year 2025 reported positive net income. These trends suggest improving earnings power alongside scale.

Investor Backing & Capital Strength: A $27M Series B round in August 2025 led by Northzone, alongside prior seed and Series A funding, indicates substantial capital support to accelerate product and go-to-market efforts. This progression signals strong investor confidence in the company’s expansion plans.

Market Expansion: The platform is described as serving home-service professionals across all 50 U.S. states and reports more than 6,000 small businesses using its solutions. Company materials also note a rise in cumulative customer booked revenue from $655M+ to $1.2B+, suggesting broader reach and usage.

Innovation-Driven Growth: New AI capabilities—including an app and the ‘Sidekick’ assistant for calls, follow-ups, quotes, and payments—extend the product beyond websites into day-to-day operations. Ongoing investment in AI features supports deeper adoption and potential future monetization.

Strong Revenue Growth: Revenue is rising steadily, including 11% year-over-year growth to $192.8 million in Q2 2026 and 7% growth for full-year 2025. The step-up from 6% growth in Q1 2026 to 11% in Q2 indicates accelerating momentum.

Profitability: Adjusted EBITDA increased 30% year over year in Q2 2026 as margin expanded from 34% to 37%, signaling operating leverage. Net income also improved to $19.4 million from $11.1 million year over year in that quarter.

Healthy Cash Flow: Guidance points to free-cash-flow growth in the high-40% range for 2026 alongside adjusted EBITDA growth of more than 20%. Operating cash flow reached $57.4 million in Q2 2026.